Assessment of laboratory indicators of inflammatory, infection and indicators of subclinical atherosclerosis in patients with systemic lupus erythematosus

The aim of the study was to reveal the relationship between the activity of inflammation, the infectious component, platelet function and dyslipidemia, in the development of subclinical atherosclerosis in patients with systemic lupus erythematosus (SLE).Material and methods. Fifty women with SLE at...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Arshinov, N. Yu. Levshin, I. G. Maslova, A. A. Baranov, V. I. Emanuylov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2024-12-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/3660
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849400813511770112
author A. V. Arshinov
N. Yu. Levshin
I. G. Maslova
A. A. Baranov
V. I. Emanuylov
author_facet A. V. Arshinov
N. Yu. Levshin
I. G. Maslova
A. A. Baranov
V. I. Emanuylov
author_sort A. V. Arshinov
collection DOAJ
description The aim of the study was to reveal the relationship between the activity of inflammation, the infectious component, platelet function and dyslipidemia, in the development of subclinical atherosclerosis in patients with systemic lupus erythematosus (SLE).Material and methods. Fifty women with SLE at the age of 52.0 [48.0–58.0] years and disease duration – 11.5 [6.0– 22.0] years were examined. The control group consisted of 21 healthy women. The concentration of high-sensitivity C-reactive protein (hsCRP), interleukin 6 (IL-6), IgG antibodies to Chlamydia pneumonia (at IgG CP), the level of Toll-like receptor (TLR2), platelet factor 4 (PF4) and antibodies to oxidized high-density lipoproteins (at oxLDL) were determined by enzyme immunoassay. Platelet aggregation indices, lipid spectrum, intima-media thickness (IMT) of common carotid arteries were investigated.Results. A significant increase in IMT of the common carotid artery (1.00 [0.80–1.10] and 0.80 [0.70–0.90] mm, respectively; p<0.01) and TKIM of the carotid bifurcation (1.10 [1.00–1.20] and 0.80 [0.70–1.10] mm, respectively; p<0.01), increased hsCRP concentration (3.67 [2.17–5.92] and 0.74 [0.30–1.26] mg/L, respectively; p<0.01), IL-6 (1.72 [1.39–2.68] and 0.60 [0.22–0.75] pg/mL, respectively; p<0.01). Significant platelet activation was noted in SLE: significant increase in TF4 concentration (21.5 [19.80–23.28] and 18.30 [13.88–20.46] ng/mL, respectively; p<0.01), marked dyslipidemia, increased concentration of oxLDL (3.16 [1.45–4.60] and 1.39 [1.26–2.04] kp, respectively; p<0.01). At IgG CP concentration and TLR2 values in patients with SLE did not differ from controls.Conclusion. In addition to traditional risk factors for the development of cardiovascular disease, the association between SLE and subclinical atherosclerotic lesions of the vascular wall can be explained by additional risk factors – inflammation and autoimmune processes. The role of the infectious component is for further study.
format Article
id doaj-art-a67a223fab26406fa0134091a3c74874
institution Kabale University
issn 1995-4484
1995-4492
language Russian
publishDate 2024-12-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-a67a223fab26406fa0134091a3c748742025-08-20T03:37:54ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922024-12-0162663363910.47360/1995-4484-2024-633-6393036Assessment of laboratory indicators of inflammatory, infection and indicators of subclinical atherosclerosis in patients with systemic lupus erythematosusA. V. Arshinov0N. Yu. Levshin1I. G. Maslova2A. A. Baranov3V. I. Emanuylov4Yaroslavl State Medical UniversityYaroslavl State Medical UniversityYaroslavl State Medical UniversityYaroslavl State Medical UniversityYaroslavl State Medical UniversityThe aim of the study was to reveal the relationship between the activity of inflammation, the infectious component, platelet function and dyslipidemia, in the development of subclinical atherosclerosis in patients with systemic lupus erythematosus (SLE).Material and methods. Fifty women with SLE at the age of 52.0 [48.0–58.0] years and disease duration – 11.5 [6.0– 22.0] years were examined. The control group consisted of 21 healthy women. The concentration of high-sensitivity C-reactive protein (hsCRP), interleukin 6 (IL-6), IgG antibodies to Chlamydia pneumonia (at IgG CP), the level of Toll-like receptor (TLR2), platelet factor 4 (PF4) and antibodies to oxidized high-density lipoproteins (at oxLDL) were determined by enzyme immunoassay. Platelet aggregation indices, lipid spectrum, intima-media thickness (IMT) of common carotid arteries were investigated.Results. A significant increase in IMT of the common carotid artery (1.00 [0.80–1.10] and 0.80 [0.70–0.90] mm, respectively; p<0.01) and TKIM of the carotid bifurcation (1.10 [1.00–1.20] and 0.80 [0.70–1.10] mm, respectively; p<0.01), increased hsCRP concentration (3.67 [2.17–5.92] and 0.74 [0.30–1.26] mg/L, respectively; p<0.01), IL-6 (1.72 [1.39–2.68] and 0.60 [0.22–0.75] pg/mL, respectively; p<0.01). Significant platelet activation was noted in SLE: significant increase in TF4 concentration (21.5 [19.80–23.28] and 18.30 [13.88–20.46] ng/mL, respectively; p<0.01), marked dyslipidemia, increased concentration of oxLDL (3.16 [1.45–4.60] and 1.39 [1.26–2.04] kp, respectively; p<0.01). At IgG CP concentration and TLR2 values in patients with SLE did not differ from controls.Conclusion. In addition to traditional risk factors for the development of cardiovascular disease, the association between SLE and subclinical atherosclerotic lesions of the vascular wall can be explained by additional risk factors – inflammation and autoimmune processes. The role of the infectious component is for further study.https://rsp.mediar-press.net/rsp/article/view/3660systemic lupus erythematosusinflammationplateletschlamydia pneumoniatlr2atherosclerosis
spellingShingle A. V. Arshinov
N. Yu. Levshin
I. G. Maslova
A. A. Baranov
V. I. Emanuylov
Assessment of laboratory indicators of inflammatory, infection and indicators of subclinical atherosclerosis in patients with systemic lupus erythematosus
Научно-практическая ревматология
systemic lupus erythematosus
inflammation
platelets
chlamydia pneumonia
tlr2
atherosclerosis
title Assessment of laboratory indicators of inflammatory, infection and indicators of subclinical atherosclerosis in patients with systemic lupus erythematosus
title_full Assessment of laboratory indicators of inflammatory, infection and indicators of subclinical atherosclerosis in patients with systemic lupus erythematosus
title_fullStr Assessment of laboratory indicators of inflammatory, infection and indicators of subclinical atherosclerosis in patients with systemic lupus erythematosus
title_full_unstemmed Assessment of laboratory indicators of inflammatory, infection and indicators of subclinical atherosclerosis in patients with systemic lupus erythematosus
title_short Assessment of laboratory indicators of inflammatory, infection and indicators of subclinical atherosclerosis in patients with systemic lupus erythematosus
title_sort assessment of laboratory indicators of inflammatory infection and indicators of subclinical atherosclerosis in patients with systemic lupus erythematosus
topic systemic lupus erythematosus
inflammation
platelets
chlamydia pneumonia
tlr2
atherosclerosis
url https://rsp.mediar-press.net/rsp/article/view/3660
work_keys_str_mv AT avarshinov assessmentoflaboratoryindicatorsofinflammatoryinfectionandindicatorsofsubclinicalatherosclerosisinpatientswithsystemiclupuserythematosus
AT nyulevshin assessmentoflaboratoryindicatorsofinflammatoryinfectionandindicatorsofsubclinicalatherosclerosisinpatientswithsystemiclupuserythematosus
AT igmaslova assessmentoflaboratoryindicatorsofinflammatoryinfectionandindicatorsofsubclinicalatherosclerosisinpatientswithsystemiclupuserythematosus
AT aabaranov assessmentoflaboratoryindicatorsofinflammatoryinfectionandindicatorsofsubclinicalatherosclerosisinpatientswithsystemiclupuserythematosus
AT viemanuylov assessmentoflaboratoryindicatorsofinflammatoryinfectionandindicatorsofsubclinicalatherosclerosisinpatientswithsystemiclupuserythematosus